Auckland, New Zealand, 28 August 2019 - Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held in Auckland today were passed. The seven resolutions were: 

Resolution 1: To re-elect Lewis Gradon as a Director. 

Resolution 2: To re-elect Donal O’Dwyer as a Director. 

Resolution 3: To elect Neville Mitchell as a Director. 

Resolution 4: To authorise the Directors to fix the fees and expenses of the Company’s auditor. 

Resolution 5: To approve the issue of share rights to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2019. 

Resolution 6: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2019. 

Resolution 7: To revoke the Company’s current constitution and adopt an updated constitution. 

All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:
 

Resolution	Votes For	%	Votes Against	Total Votes Cast	Abstain
Resolution 1 Re-election of Lewis Gradon	366,211,794	99.99	34,786	366,506,224	259,644
Resolution 2: Re-election of Donal O’Dwyer	362,028,570	98.84	4,255,366	366,506,224	222,288
Resolution 3: Election Neville Mitchell	366,310,274	99.99	27,823	366,506,224	168,127
Resolution 4: Authorise Directors to fix fees and expenses of auditor	366,032,085	99.92	304,778	366,506,224	169,361
Resolution 5: Issue of share rights to Lewis Gradon	340,475,664	93.13	25,123,366	365,902,722	303,692
Resolution 6: Issue of options to Lewis Gradon	338,904,512	92.70	26,669,393	365,902,722	328,817
Resolution 7: Revoke constitution and adopt updated constitution	366,139,655	99.98	72,793	366,506,224	293,776

Contact: Marcus Driller, VP – Corporate and Company Secretary on +64 9 574 0110. For more information about the company visit our website www.fphcare.com

 

About Fisher & Paykel Healthcare

Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Ends

 

Contact

Investors: Hayden Brown Investor Relations Manager hayden.brown@fphcare.co.nz +64 (0) 27 807 8073   Media: Karen Knott Senior Communications Manager karen.knott@fphcare.co.nz +64 (0) 21 713 911